Adenosine Deaminase in the Diagnosis of Tuberculous Pleural Effusion : Is It Really an Ideal Test?

A Word of Caution
Rafael Laniado-Laborn Chest 2005;127;417-418 DOI 10.1378/chest.127.2.417 The online version of this article, along with updated information and services can be found online on the World Wide Web at: http://chestjournal.chestpubs.org/content/127/2/417.full.html

Chest is the official journal of the American College of Chest Physicians. It has been published monthly since 1935. Copyright2005by the American College of Chest Physicians, 3300 Dundee Road, Northbrook, IL 60062. All rights reserved. No part of this article or PDF may be reproduced or distributed without the prior written permission of the copyright holder. (http://chestjournal.chestpubs.org/site/misc/reprints.xhtml) ISSN:0012-3692

Downloaded from chestjournal.chestpubs.org by guest on October 3, 2011 2005 American College of Chest Physicians

CHEST
Adenosine Deaminase in the Diagnosis of Tuberculous Pleural Effusion
Is It Really an Ideal Test? A Word of Caution
the low sensitivity and/or specificity of noninvasive traditional diagnostic tools. In most series of patients with TPE, the results of pleural fluid staining for acid-fast bacilli are virtually always negative, and pleural fluid cultures are positive for mycobacteria in 25% of cases. On the other hand, a pleural biopsy specimen will demonstrate granulomatous pleuritis in 80% of patients with TPE, and when a culture of a biopsy specimen is combined with histologic examination, the diagnosis can be established in approximately 90% of cases.1 Tuberculous pleurisy is thought to be the result of a delayed hypersensitivity reaction in response to the presence of mycobacterial antigens in the pleural space.2 This immunologic reaction causes the stimulation and differentiation of lymphocytes, which release lymphokines, which in turn activate macrophages for an enhanced bactericidal effect.2 The levels of adenosine deaminase (ADA), an enzyme found in most cells, are increased in tuberculous pleural effusions, and this determination has acquired popularity as a diagnostic test in highincidence areas for TPE because it is not invasive, the assay is not expensive, and it is readily accessible. ADA is involved in the proliferation and differentiation of lymphocytes, especially T lymphocytes. They release ADA when stimulated in the presence of live intracellular microorganisms.3 For this reason, ADA has been looked on as a marker of cell-mediated immunity and, in particular, as a marker of the activation of T lymphocytes. Several reports3 have suggested that an elevated pleural fluid ADA level predicts tuberculous pleuritis with a sensitivity of 90 to 100% and a specificity of 89 to 100%.There are several isoforms of ADA, but the prominent ones are ADA1 and ADA2. ADA1 is present in all cells, whereas ADA2 is found only in
www.chestjournal.org

editorials
VOLUME 127 / NUMBER 2 / FEBRUARY, 2005

definite diagnosis of tuberculous A sion (TPE) can be difficult to makepleural effubecause of

monocytes.4 ADA2 is the predominant isoform in TPEs, accounting for most of the total ADA activity, however, in clinical practice the difference in the use of total ADA or the isoform ADA2 is not considered to be significant. Furthermore, the isoenzyme assay is more expensive and not readily available.2 The reported cutoff value for ADA varies from 47 to 60 U/L3. Specificity is increased when the lymphocyte/neutrophil ratio in the pleural fluid (of 0.75) is considered together with an ADA concentration of 50 U/L.5 Some of the discrepancy in the results among the studies reported in the literature can be attributed to the use of different methods for ADA analysis, with the most frequently reported method being the colorimetric ADA assay described by Guisti and Galanti.6 Consequently, when interpreting results, physicians should be conscious of the differing cutoff levels that can occur with the different methods of ADA analysis.7 Also, we should be aware that ADA levels in pleural fluid maintained at ambient temperature, as reported by Miller et al,8 will decrease with time. As they elegantly demonstrated in their study, the addition of glycerol and ethylene glycol or glycerol and sodium sulfate to pleural fluid stabilizes ADA levels for up to 3 weeks at 37C, obviating the need to freeze or refrigerate the specimens while awaiting analysis. An ideal test for tuberculous pleurisy should be economic, minimally invasive, of high accuracy, and quick to perform. The ADA test has been hailed lately as the ideal test for the diagnosis of TPE. However, this test has some limitations that should be taken into consideration when facing the challenge of diagnosing a pleural effusion of unknown origin. In practice, the ability to predict the presence or absence of disease from test results is dependent on the prevalence of the disease in the population tested, as well as on the sensitivity and specificity of the test. Even when utilizing a test with very high sensitivity and specificity (for example the ADA test), when the prevalence of disease in the population is low (ie, 1%), such as that of TPE in developed countries, the predictive value of a positive test, or the proportion of true-positive results among all
CHEST / 127 / 2 / FEBRUARY, 2005

417

Downloaded from chestjournal.chestpubs.org by guest on October 3, 2011 2005 American College of Chest Physicians

those who have positive test results, can be as low as 15% (this means that 85% of the subjects with a positive test result will not have a TPE).9 The incidence of TPE is generally associated with the regional prevalence of tuberculosis.2 In the United States, only a small proportion of exudative pleural effusions are caused by tuberculosis.10 In TPE, a lymphocyte-dominant pleurisy, ADA is released in the presence of live intracellular Mycobacterium tuberculosis. It is thought that false-positive diagnoses of TPE by ADA level determination can be significantly reduced if ADA measurement is limited to lymphocytic pleural fluids. Theoretically, however, other lymphocyte-rich pleural effusions associated with live intracellular microorganisms also could have elevated ADA pleural fluid levels,11 including those caused by coccidioidomycosis and histoplasmosis, which are endemic mycoses in vast areas of the United States. High levels of ADA also have been reported in noninfectious conditions associated with pleural fluid lymphocytosis, including malignant conditions (eg, adenocarcinomas, leukemias, and lymphomas) and collagen vascular diseases (eg, rheumatoid pleuritis and systemic lupus erythematosus),5,7 which make the test less useful in countries with a low prevalence of tuberculosis.12,13 Therefore, an increased ADA level should not be considered as an equivalent to the presence of mycobacteria in the pleural fluid or pleural biopsy specimens.2 A higher rate of falsepositive test results can lead to the unnecessary administration of antituberculous therapy or a delay in making an alternative diagnosis. In areas with a high prevalence of tuberculosis, the proportion of false-positive results will be obviously lower. However, a limitation of the test in this setting, as a sole method of diagnosis, is that culture results will not be available to guide antituberculosis chemotherapy. Culture results are particularly necessary if drug-resistant tuberculosis is prevalent,10 an increasingly frequent scenario in countries with high rates of tuberculosis. Patients with drug-resistant tuberculosis may receive treatment with inefficient drugs due to the lack of availability of culture and drug-sensitivity results. With the decline in the prevalence of TPE, the positive predictive value of pleural fluid ADA also declines, but the negative predictive value actually increases. Therefore, the measurement of the pleural fluid ADA level could be used to rule out a tuberculous etiology of lymphocytic pleural effusions, regardless of the rate of prevalence of the disease.2,4 In conclusion, the ADA assay should not be considered as an alternative to biopsy and culture, but rather as a screening test to guide further
418

diagnostic procedures and management of an exudative pleural effusion of unknown origin.2,3 Rafael Laniado-Laborn, MD, MPH, FCCP San Ysidro, CA
Dr. Laniado-Laborn is affiliated with the Facultad de Medicina Tijuana, Universidad Autonoma de Baja California, Mexico. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (e-mail: permissions@chestnet.org). Correspondence to: Rafael Laniado-Laborn, MD, MPH, FCCP, PMB 953, 482 W San Ysidro Blvd, No. 2, San Ysidro, CA 92173; e-mail: rafaellaniado@hotmail.com

References
1 Light RW. Pleural diseases. 3rd ed. Baltimore, MD: William & Wilkins, 1995; 154 166 2 Kataria YP, Khurshid I. Adenosine deaminase in the diagnosis of tuberculous pleural effusion. Chest 2001; 120:334 336 3 Roth BJ. Searching for tuberculosis in the pleural space. Chest 1999; 116:35 4 Jimenez Castro D, Daz Nuevo G, Perez-Rodrguez E, et al. Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J 2003; 21:220 224 5 Burgess LJ, Maritz FJ, Le Roux I, et al. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio: increased specificity for the diagnosis of tuberculous pleuritis. Chest 1996; 109:414 419 6 Guisti G, Galanti B. Methods in enzymatic analysis. New York, NY: Academic Press, 1974; 10921096 7 Riantawan P, Chaowalit P, Wongsangiem M, et al. Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis. Chest 1999; 116:97103 8 Miller KD, Barnette R, Light RW. Stability of adenosine deaminase during transportation. Chest 2004; 126:19331937 9 Sackett DL, Haynes RB, Guyat GH, et al. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. Philadelphia, PA: Little & Brown, 1991; 69 152 10 Light RW. Establishing the diagnosis of tuberculosis pleuritis [editorial]. Arch Intern Med 1998; 158:19671968 11 Dickensoy O, Namiduru M, Hocaoglu S, et al. Increased pleural fluid adenosine deaminase in brucellosis is difficult to differentiate from tuberculosis. Respiration 2002; 69:556 559 12 Maskell NA, Butland RJ. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003; 58(suppl):ii8 ii17 13 Lee YCG, Light RW. Adenosine deaminase for lymphocytic pleural effusions. International Pleural Newsletter 2004; 2:5 6

Endoscopic Ultrasound-Guided Fine-Needle Aspiration Staging of Lung Cancer

Is It Time To Go Beyond Cytology?
ndoscopic ultrasonography E imaging modality in which(EUS) is a unique a high-frequency

ultrasound transducer is incorporated into the tip of an endoscope to provide high-resolution images of
Editorials

Downloaded from chestjournal.chestpubs.org by guest on October 3, 2011 2005 American College of Chest Physicians

Adenosine Deaminase in the Diagnosis of Tuberculous Pleural Effusion : Is It Really an Ideal Test? A Word of Caution Rafael Laniado-Laborn Chest 2005;127; 417-418 DOI 10.1378/chest.127.2.417 This information is current as of October 3, 2011
Updated Information & Services Updated Information and services can be found at: http://chestjournal.chestpubs.org/content/127/2/417.full.html References This article cites 10 articles, 7 of which can be accessed free at: http://chestjournal.chestpubs.org/content/127/2/417.full.html#ref-list-1 Cited Bys This article has been cited by 2 HighWire-hosted articles: http://chestjournal.chestpubs.org/content/127/2/417.full.html#related-urls Permissions & Licensing Information about reproducing this article in parts (figures, tables) or in its entirety can be found online at: http://www.chestpubs.org/site/misc/reprints.xhtml Reprints Information about ordering reprints can be found online: http://www.chestpubs.org/site/misc/reprints.xhtml Citation Alerts Receive free e-mail alerts when new articles cite this article. To sign up, select the "Services" link to the right of the online article. Images in PowerPoint format Figures that appear in CHEST articles can be downloaded for teaching purposes in PowerPoint slide format. See any online figure for directions.

Downloaded from chestjournal.chestpubs.org by guest on October 3, 2011 2005 American College of Chest Physicians